Vitamin D, 25-Hydroxy (Total)
Vitamin markersWhat the test generally measures, and what to ask about it.
Longetic keeps every lab and record you’ve had organized and easy to find, so your own Vitamin D, 25-Hydroxy (Total) values sit together on one chart and you walk into your next appointment prepared.
Total 25-hydroxyvitamin D [25(OH)D] is the standard blood test for vitamin D status. It adds up D2 and D3 forms from sun, food, and supplements. Major health organizations use different cutoffs for "sufficient," so labs may flag the same result differently. Longetic keeps every result organized alongside your history, so you can bring it up with your doctor.
What is Vitamin D, 25-Hydroxy (Total)?
Total 25-hydroxyvitamin D [25(OH)D] is the standard blood test for vitamin D status.
When your skin makes vitamin D from sunlight, or you get it from food or a supplement, your liver converts it into 25-hydroxyvitamin D, written as 25(OH)D. This is the form that circulates in your blood for weeks, which makes it the marker labs measure to check vitamin D status. It's different from the active hormone form, 1,25-dihydroxyvitamin D (calcitriol), which your kidneys make on demand, has a much shorter half-life, and is only tested in specific clinical situations, not as a routine status check. A "total" 25(OH)D result adds together two related compounds: 25-hydroxyvitamin D2, which comes from ergocalciferol (found in some fortified foods, mushrooms exposed to UV light, and some supplements), and 25-hydroxyvitamin D3, which comes from cholecalciferol (made in skin exposed to sunlight, found in animal sources, and used in most over-the-counter supplements sold in the US). Most people's results are almost entirely D3, since D2 intake is comparatively rare in Western diets. There's a genuine, still-open question in the research about whether D2 and D3 raise blood levels equally well. A 2012 meta-analysis in the American Journal of Clinical Nutrition found D3 outperformed D2 when given as an infrequent high dose, but the two performed similarly when dosed daily. A more recent meta-analysis of 11 randomized trials, published in Nutrition Reviews in September 2025, found that D2 supplementation actually lowered participants' D3 levels, on top of raising total 25(OH)D less than D3 did, though the researchers said the practical significance of that D3 drop isn't established. Neither paper is the last word. This is an area where the evidence keeps shifting, not a settled fact about one form being "better." Why does this test get ordered so often? Vitamin D status affects calcium absorption and bone metabolism, and low levels have been studied in relation to a long list of other conditions, from muscle function to immune activity. That breadth of interest is exactly why it's one of the most frequently ordered lab tests in primary care, and why so many people end up with a 25(OH)D result sitting in a portal or a PDF without much context for what it means. One technical detail worth knowing about: 25(OH)D assays have a real history of inter-laboratory variability. Different labs, using different methods, have sometimes reported meaningfully different numbers for the same blood sample. That's why the international Vitamin D Standardization Program exists, and why the Vitamin D External Quality Assessment Scheme (DEQAS) has been distributing shared samples to labs worldwide since the 1980s so they can check their assay's accuracy against a common reference. Standardization has improved considerably, but it's part of why the same numeric result can carry slightly different confidence depending on which lab and method produced it, and it's a fair question to ask your doctor's office about if you're comparing results across providers. None of this makes 25(OH)D a monitoring or diagnostic tool on its own. It's one data point clinicians read alongside your history, symptoms, and other labs, and Longetic's job is to keep that data point organized and easy to find, not to interpret it for you.
Typical reference context
| Status | Endocrine Society (2011 guideline) | Institute of Medicine / National Academies (2011 report) |
|---|---|---|
|
Deficient
|
Below 20 ng/mL (50 nmol/L)
|
Below 12 ng/mL (30 nmol/L)
|
|
Insufficient / inadequate
|
21-29 ng/mL (52.5-72.5 nmol/L)
|
12-19 ng/mL (30-50 nmol/L)
|
|
Sufficient
|
30 ng/mL (75 nmol/L) or above
|
20 ng/mL (50 nmol/L) or above, for bone health in the general population
|
|
Potential toxicity risk
|
Above 100 ng/mL discussed as an upper safety concern
|
Above 50 ng/mL flagged for review
|
Reference ranges for 25(OH)D vary by lab and by which organization's cutoffs they use. The two most-cited US sources have historically disagreed with each other, and that disagreement is worth understanding rather than papering over.
That gap between "sufficient" at 20 versus 30 ng/mL isn't a typo, and it hasn't been resolved by a single unified guideline since. The Endocrine Society's 2011 panel was writing for people already being clinically evaluated for vitamin D-related conditions. The Institute of Medicine's 2011 report was setting population-wide dietary reference intakes for essentially everyone. Both bodies have stood by the reasoning behind their own number. As explained below, the Endocrine Society's 2024 update changed its approach in a different way, rather than picking a side in this specific 20-versus-30 debate. The most important thing a specific number on your own report doesn't tell you is what it means for you personally, which is a conversation for your doctor, not a lookup table.
What changed recently
The Endocrine Society replaced its 2011 guideline in June 2024, publishing "Vitamin D for the Prevention of Disease" in the Journal of Clinical Endocrinology & Metabolism. The new guideline is a notable shift in shape, not just numbers: rather than naming a general blood-level target like the old 30 ng/mL, it says outcome-specific benefits of particular 25(OH)D levels "have not been established in clinical trials," and it recommends against routine 25(OH)D testing for healthy people under 75. It suggests against supplementing beyond the standard dietary intake for most adults under 75, but it does suggest empiric (not blood-level-guided) supplementation for four specific groups: children and adolescents, pregnant people, adults 75 and older, and adults with high-risk prediabetes, based on trial evidence in those groups specifically. The IOM's 2011 population-wide intake recommendations, now maintained by the National Academies, have not been revised with a comparable update as of this writing, so the 20-versus-30 ng/mL disagreement above is still unresolved between the two source documents themselves.
A large 2026 meta-analysis published in The BMJ pooled 69 randomized controlled trials covering 153,902 adults and found that vitamin D supplementation alone, calcium alone, and combined calcium-plus-vitamin-D all showed little to no clinically meaningful benefit for preventing fractures or falls, with the vitamin D-alone finding rated high certainty. The authors were careful to note this doesn't necessarily apply to people with diagnosed bone conditions or those on specific osteoporosis treatment, and they didn't study vitamin D's other proposed roles, so it's a fracture-and-falls finding specifically, not a verdict on vitamin D overall.
Together, these two developments point in the same direction: less confidence in blood-level targets and more caution about assuming supplementation changes hard outcomes for most people, alongside continued support for supplementation in a few specific groups with clearer trial evidence.
Tests often checked alongside this
Parathyroid hormone (PTH) rises when calcium regulation is under strain, which can happen with very low vitamin D status. Calcium (serum) is checked together with vitamin D since vitamin D affects how much calcium your gut absorbs. Phosphate is involved in the same bone-mineral pathway.
What can affect this marker
Season and sun exposure matter, since levels typically run higher after summer and lower at the end of winter in temperate climates. Skin tone and body composition play a role too: more melanin reduces UVB-driven synthesis efficiency, and vitamin D is fat-soluble, so it distributes differently depending on body composition. Diet and supplement use, and which form you take, matter as well, since D2 and D3 sources may not move your number identically. Biotin interference is worth knowing about, since high-dose biotin supplements can interfere with certain immunoassay-based vitamin D tests. Assay method matters too, since different testing methods have a real history of producing different numbers for the same sample.
What to ask your doctor
- What method does this lab use for the 25(OH)D test, and could biotin or other supplements I take interfere with it?
- Given the newer 2024 guidance, do I fall into one of the specific groups where supplementation is suggested?
- If I'm taking a vitamin D supplement, is there a reason to prefer D3 over D2, or does it not matter for my situation?
- Is there a reason to also check calcium or PTH alongside this result?
This glossary entry is for informational purposes only and is not a substitute for professional medical advice. Read our Terms of Use.
Frequently asked questions
References
About our sources
Official sources
Government health agencies, national institutes, and intergovernmental bodies whose guidelines carry regulatory or policy weight.
Clinical / professional
Medical societies, specialty colleges, and professional associations whose consensus statements reflect clinical practice standards.
Peer-reviewed research
Original research articles and systematic reviews published in indexed journals and verified through PubMed or DOI.
